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Abstract  SA Fam Pract 2010;52(1):55-59
Background: Anaemia occurs widely among people living with HIV/AIDS. The aim of this study was to investigate the effect of HIV status on iron 
status, more specifically to investigate the nutritional health of women between 25 and 44 years of age.
Methods: An epidemiological study was undertaken in Mangaung, a black residential community of Bloemfontein in the Free State (South Africa). 
A random sample consisted of 500 women in two age groups (25–34 [n = 273] and 35–44 years [n = 215]). Blood specimens were collected in 
ethyldimethylacetic acid  collection tubes according to standard procedures. Respondents fasted overnight, abstained from exercise and avoided 
consuming alcohol and caffeine for 24 hours prior to collection of the blood specimens. All specimens were taken in the morning. A full blood 
count was performed using a Coulter Microdiff 18 Cell Counter. The metabolic variables haematocrit (Hct), haemoglobin (Hb), serum iron, ferritin 
and transferrin were determined. The red blood cell count was performed to calculate the mean corpuscular volume (MCV), mean corpuscular 
haemoglobin (MCH) and mean corpuscular haemoglobin concentration (MCHC). Age and HIV-status groups were described and compared by non-
parametric methods. A p-value lower than 0.05 was considered significant. HIV-infected and -uninfected groups were compared by 95% confidence 
intervals for the difference in the percentage of women with parameters below or above the normal range.
Results: Sixty-one per cent of the younger women and 38% of the older women were HIV infected. The percentage with serum ferritin levels below 
20 µg/L was higher in HIV-uninfected women, ranging from 0% in older HIV-infected women to 10.4% in younger HIV-uninfected women. A large 
percentage of women had elevated transferrin values, ranging from 23.9% in older HIV-infected women to 44.8% in older HIV-uninfected women. 
A large percentage of women had anaemia of chronic disease, with HIV-infected women afflicted more often.
Conclusion: The results of the study indicate that prevalence of HIV infection in Mangaung is high, especially among women between 25 and 
34 years of age. Although the parameters of iron status on average did not indicate iron deficiency in the different age and HIV-status groups, a large 
percentage of women did have anaemia of chronic disease, with HIV-infected women afflicted more often. Knowledge of the HIV status of a patient 
is of paramount importance in evaluating laboratory results of iron levels to determine future treatment or nutritional recommendations. HIV-infected 
and -uninfected individuals might not be comparable regarding their laboratory results to interpret iron store depletion, with consequences for further 
therapeutic actions in these two groups. The progression rate to AIDS might also be enhanced by certain interventions.
 Peer reviewed. (Submitted: 2009-03-11, Accepted: 2009-08-10). © SAAFP 
Introduction
Nutrition is an important factor in the course of HIV infection1 and is 
generally accepted as a major determinant of immune functioning.2 
Nutritional factors, although not the most important aetiological 
determinants, may change immune function to facilitate disease 
progression, influence viral expression, and play a significant role in 
disease processes and related morbidity and mortality.3
Although the reasons are not fully understood,4 anaemia occurs widely 
among people living with HIV/AIDS.5–7 Some researchers associate 
anaemia with HIV-disease progression and an increased risk of 
death,7,8 even independent of CD4 count and viral load.9 On the other 
hand, others find no relationship between indicators of iron status and 
disease severity in HIV-infected pregnant African women.10 Anaemia can 
be associated with various conditions, including infection, neoplasms, 
dietary deficiencies, blood loss and medication.7,9 Iron deficiency 
and anaemia may contribute to reduced energy levels, lower aerobic 
capacity, decreased endurance and fatigue.11 A possible sign of early 
iron deficiency is reduced immunocompetence, which may lead to an 
increased propensity for infection.12 Olsen et al13 recommend that the role 
of iron in HIV infection be clarified, since iron is commonly administered 
to both anaemic patients and pregnant women, and as knowledge of HIV 
status is not actively sought by victims due to social stigmatisation, iron 
supplementation is a common phenomenon even in areas with a high 
HIV prevalence.
Methods and materials
An epidemiological study was undertaken in Mangaung, a black 
residential community of Bloemfontein in the Free State (South Africa). 
The main objective of the study was to investigate the nutritional health 
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of women between 25 and 44 years of age. This age group was chosen 
to coincide with the age range used in another study in the same 
geographical area, but done a number of years ago.14 As part of the 
current epidemiological study, socio-demographic status, health status 
(determined by a medical examination), dietary intake (determined 
using a comprehensive food frequency questionnaire), levels of physical 
activity, body perception and attitude toward weight control, prevalence 
and risk of lifestyle diseases, anthropometry, micronutrient status and 
prevalence of HIV were determined. This paper reports on the iron status 
of HIV-infected and -uninfected women, and whether HIV status is linked 
to changes in iron stores.
Participants
A sample size of 500 was estimated to be representative of the 
Mangaung metropole. The respondents were from two built-up areas 
(Phahameng and Botchabela) and two informal settlements (Joe Slovo 
and Namibia). Post-pubertal but pre-menopausal black women were 
randomly selected from the two age groups 25 to 34 and 35 to 44 years, 
using township maps. The residential plots in the four selected areas 
were counted and numbered. Namibia had 2  995 plots, Phahameng 
1 711, Joe Slovo 1 359 and Botchabela 2 308. A proportionate number 
of respondents were randomly selected from these plots. Twenty 
subjects were recruited per week over a 25-week period (March 2000 
– November 2000). A randomly selected residence was approached by 
a community health worker. If no one was at home, the residence to the 
right was targeted, and if still unsuccessful, the residence to the left of 
the original address was approached. If all attempts failed, another plot 
was randomly selected.
The women participated voluntarily after giving written informed consent. 
Each participant received an amount of R40.00 to cover travelling and 
other logistical costs. The study was approved by the Ethics Committee 
of the Faculty of Health Sciences, University of the Free State (ETOVS no 
02/00). The results of four women who were found to be pregnant during 
the medical examination were excluded. All participants were originally 
unaware of their HIV status, and were antiretroviral therapy (ART) naïve. 
Women who chose to be informed of their HIV status after testing 
(< 30%) were confidentially seen by a medical practitioner who referred 
HIV-infected patients for counselling and further follow-up.
Blood specimens
A registered nurse collected the blood specimens according to standard 
procedures. Respondents fasted overnight, abstained from exercise, 
and avoided consuming alcohol and caffeine for 24 hours prior to 
collection of the blood specimens. All blood specimens were taken in 
the morning. It was not possible to evaluate all the specimens due to 
clotting or haemolysis. Respondents were not requested to return for 
repeat specimens.
The methods and equipment that were used to determine the parameters 
evaluated in this study are listed in Table I.
Blood specimens were taken in ethyldimethylacetic acid (EDTA) collection 
tubes and a full blood count was performed using a Coulter Microdiff 18 
Cell Counter. The metabolic variables haematocrit (Hct), haemoglobin 
(Hb), serum iron,
ferritin and transferrin were determined. The red blood cell count 
was performed in order to calculate the mean corpuscular volume 
(MCV), mean corpuscular haemoglobin (MCH) and mean corpuscular 
haemoglobin concentration (MCHC). Counting of red and white blood 
cells was performed sequentially.
Statistical analysis
Age and HIV-status groups were described and compared by non-
parametric methods. Data were processed using the SAS software 
program.15 All datasets were categorised into two age groups (25–34 
years, and 35–44 years), and two HIV-status groups (HIV uninfected and 
HIV infected). For each group, continuous variables were described by 
medians (as data were not always equally distributed), and categorical 
variables were described by frequencies and percentages. A p-value 
lower than 0.05 was considered significant. HIV-infected and -uninfected 
groups were compared by 95% confidence intervals (CIs) for the 
difference in the percentage of women with parameters below or above 
the normal range.
Results
In this sample the prevalence of HIV infection was higher in the younger 
(25–34 years) than in the older women (35–44 years). Sixty one per 
cent of younger women and 38% of older women were HIV infected. An 
overview of the micronutrient intake of participants has been published 
previously16 and showed that the median total iron intake of women 
participating in this study did not differ significantly between those with 
low or high parameter values, independent of their age or HIV status.16
Iron status parameter median values
The median iron status parameters for the entire group are given in Table II.
The median values for all iron status parameters of HIV-infected and 
-uninfected women for both age groups fell within the normal reference 
ranges. Within these ranges, however, the younger HIV-infected women 
had significantly lower Hb (p = 0.0002) and Hct (p = 0.0003) median 
values than the HIV-uninfected group.
In the older group, the HIV-infected women had significantly lower 
median transferrin (p = 0.04) but higher median serum ferritin (s-ferritin) 
values (p = 0.02) than the HIV-uninfected women.
Iron status parameter percentages
The parameter percentages for the younger women are given in Table III 
and for the older women in Table IV.
Few women had low s-ferritin levels. However, more HIV-uninfected 
women (in both age groups) had low s-ferritin levels than infected women 
(younger group: 10.4% vs 5.3%; older group: 6.5% vs 0%). Although the 
difference was not significant, a trend was observed in both age groups, 
indicated by a 95% Wilcoxin CI [3.1; 14.4] for the younger group and 
[-2.2; 15.4] for the older group.
Table I: Methods and equipment used to determine the parameters 
evaluated in the study
Parameter Methods and equipment
HIV tests
Human Immunodeficiency Viruses (HIV-1/HIV-2: 
recombinant antigens and synthetic peptides) reagent 
pack (Abbott, Germany, catalogue no 3D41-20)
Total serum ferritin
Determined on the Hitachi 902 using an 
immunoturbidimetric immunoassay supplied by 
Randox (catalogue no FN 2467)
Total serum iron
Determined on the Hitachi 902 using a colorimetric 
assay method (catalogue no 11876996, Boehringer 
Mannheim-Roche Diagnostics, Mannheim, Germany)
Total serum transferrin
Determined on the Hitachi 902 using an 
immunoturbidimetric immunoassay supplied by 
Randox (catalogue no TF 7197)
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Table II: Median values for iron status parameters of HIV-uninfected and HIV-infected women in both younger and older age groups
Parameter Normal range
25–34 years 35–44 years
HIV -* HIV +* HIV - HIV +
n Median n Median n Median n Median
Serum ferritin (µg/L) 20–200 77 63.9 95 74.1 62 57.4† 46 80†
Serum iron (mg/L) 0.7–1.8 93 0.9 116 0.9 62 0.9 53 0.9
Transferrin (g/L) 2.0–3.0 68 2.9 85 2.8 58 3† 46 2.8†
Transferrin saturation (%) 20–50 68 25.4 85 26 58 24.1 46 23.8
Haemoglobin (g/dL) 11.7–16.0 106 14.1† 166 13.6† 131 13.7 82 13.5
Haematocrit (L/L) 0.35–0.47 106 40.9† 166 39.2† 131 39.5 82 39.8
MCV (fL) 81–99 106 89.7 166 89.9 131 91.5 82 91.5
MCH (pg) 27–34 106 30.5 166 30.9 131 31.3 82 31.2
MCHC (g/dL) 32–36 106 33.9 166 34.1 131 34.2 82 34.1
*HIV -: HIV-uninfected; HIV +: HIV-infected; †statistically significant
Table III: Iron status parameter percentages for HIV-infected and  
HIV-uninfected women in the 25- to 34-year age group
Parameter
HIV -* HIV +*
95% CI
n % n %
Serum ferritin (μg/L): (n = 77) (n = 95)
   < 20 8 10.4 5 5.3 -3.1;14.4
   20–200 67 87 87 91.6
   > 200 2 2.6 3 3.2
Serum iron (mg/L): (n = 93) (n = 116)
   < 0.7 28 30.1 42 36.2 -16.6;4.8
   0.7–1.8 59 63.4 68 58.6
   > 1.8 6 6.5 6 5.2
Transferrin (g/L): (n = 68) (n = 85)
   < 2.0 1 1.5 4 4.7 -8.7;2.3
   2.0–3.0 45 66.2 55 64.7
   > 3.0 22 32.4 26 30.6 -12.6;16.5
Transferrin saturation (%): (n = 68) (n = 85)
   < 20 22 32.4 26 30.6 -10.4;14.2
   20–50 41 60.3 51 60
   > 50 5 7.4 8 9.4
Haemoglobin (g/dL): (n = 106) (n = 166)
   < 11.7 5 4.7 16 9.6 -11.0;2.0
   11.7–16.0 95 89.6 148 89.2
   > 16.0 6 5.7 2 1.2
Haematocrit (L/L): (n = 106) (n = 166)
   < 0.35 5 4.7 22 13.3 -14.0;-2.5†
   0.35–0.47 95 89.6 144 86.8
   > 0.47 6 5.7 0 0
MCV (fL): (n = 106) (n = 166)
   < 81 10 9.4 14 8.4 -5.7;8.8
   81–99 92 86.8 144 86.8
   > 99 4 3.8 8 4.8
MCH (pg): (n = 106) (n = 166)
   < 27 10 9.4 12 7.2 -4.3;9.9
   27–34 91 85.9 147 88.6
   > 34 5 4.7 7 4.2
MCHC (g/dL): (n = 106) (n = 166)
   < 32 9 8.5 5 3 0.0;12.6
   32–36 91 85.9 158 95.2
   > 36 6 5.7 3 1.8
*HIV -: HIV-uninfected; HIV +: HIV-infected; †statistically significant
Table IV: Iron status parameter percentages for HIV-infected and  
HIV-uninfected women in the 35- to 44-year age group
Parameter
HIV -* HIV +*
95% CI
n % n %
Serum ferritin (μg/L): (n = 62) (n = 46)
   < 20 4 6.5 0 0 -2.2;15.4
   20–200 51 82.3 44 95.7
   > 200 7 11.3 2 4.4
Serum iron (mg/L): (n = 62) (n = 53)
   < 0.7 25 40.3 13 24.5 1.3;29.2†
   0.7–1.8 28 45.2 39 73.6
   > 1.8 9 14.5 1 1.9
Transferrin (g/L): (n = 58) (n = 46)
   < 2.0 0 0 2 4.4 -12.4;1.0
   2.0–3.0 32 55.2 33 71.7
   > 3.0 26 44.8 11 23.9 2.4;37.1†
Transferrin saturation (%): (n = 58) (n = 46)
   < 20 21 36.2 14 30.4 -9.6;20.4
   20–50 30 51.7 30 65.2
   > 50 7 12.1 2 4.4
Haemoglobin (g/dL): (n = 131) (n = 82)
   < 11.7 6 4.6 7 8.5 -12.4;2.7
   11.7–16.0 121 92.4 72 87.8
   > 16.0 4 3.1 3 3.7
Haematocrit (L/L): (n = 131) (n = 82)
   < 0.35 3 2.3 10 12.2 -17.2;-4.1†
   0.35–0.47 123 93.9 69 84.2
   > 0.47 5 3.8 3 3.7
MCV (fL): (n = 131) (n = 82)
   < 81 8 6.1 2 2.4 -3.1;9.4
   81–99 112 85.5 75 91.5
   > 99 11 8.4 5 6.1
MCH (pg): (n = 131) (n = 82)
   < 27 10 7.6 2 2.4 -1.7;11.3
   27–34 108 82.4 75 91.5
   > 34 13 9.9 5 6.1
MCHC (g/dL): (n = 131) (n = 82)
   < 32 10 7.6 1 1.2 0.0;12.3
   32–36 108 82.4 76 92.7
   > 36 13 9.9 5 6.1
*HIV -: HIV-uninfected; HIV +: HIV-infected; †statistically significant
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Compared to s-ferritin levels, a larger percentage of women had serum 
iron levels below 0.7 mg/L. In the younger group there was no significant 
difference between the HIV-infected and -uninfected women (95% 
CI [-16.6;  4.8]). In the older group, however, significantly more HIV-
uninfected women had low serum iron levels (95% CI [1.3; 29.2]).
Very few women had low transferrin levels. Although more HIV-infected 
women had low transferrin levels, the difference was not significant for 
either age group. More than 20% of all women, however, had elevated 
transferrin levels above 3.0 g/L. In the older age group the elevated 
transferrin was significantly more pronounced in the HIV-uninfected than 
in the HIV-infected group (95% CI [2.4; 37.1]).
The percentage of women with transferrin saturation below 20% was 
highest in the older age group (both HIV-infected and HIV-uninfected 
women). In both age groups, this percentage did not differ significantly 
between the two HIV-status groups. Similarly, no significant difference 
was seen in the percentage of women with elevated transferrin saturation 
above 50% between HIV-infected and -uninfected states.
The percentage of women with low Hb levels ranged from 4.6% in 
the older HIV-uninfected women to 9.6% in the younger HIV-infected 
women. Although the HIV-infected groups (both age intervals) had a 
higher percentage of low Hb values and the confidence interval indicated 
a trend, the difference was not statistically significant (younger group: 
95% CI [-11; 2.0]; older group: 95% CI [-12.4; 2.7]).
Similarly, the percentage of women with low Hct levels ranged from 
2.3% (older HIV-uninfected women) to 13.3% (younger HIV-infected 
women). In both younger and older women, significantly more women 
had low Hct values in the HIV-infected groups with 95% CI [-14.0; -2.5] 
(younger group) and 95% CI [-17.2; -4.1] (older group).
No significant differences between MCV and MCH of HIV-infected and 
-uninfected women could be found in either age group. The percentage 
of women with low MCHC, however, seemed more pronounced in the 
HIV-uninfected women. The difference was close to significant with 
95% CIs [0.00; 12.6] and [0.0; 12.3], in the younger and older groups, 
respectively. The percentage of women with low MCHC ranged from 
1.2% in the older HIV-infected women to 8.5% in the younger HIV-
uninfected women.
Discussion
Prevalence of HIV in the random sample included in this study was very 
high. In developing countries, a disturbing trend of a faster growing 
rate of new infections in females than in males is being witnessed,17,18 
with women of childbearing age infected at the highest rate of all 
subgroups.19
Nutritional deficiencies may develop during any stage in the HIV-
infected individual. Because the early signs and symptoms of nutritional 
deficiencies, such as fatigue, irritability and dry skin are non-specific, 
many deficiencies remain unnoticed until they have progressed to levels 
of expressive body depletion.20
S-ferritin levels are usually in equilibrium with body iron stores and 
measurements of s-ferritin may best reveal an early negative iron 
balance,12 while high s-ferritin may indicate significant iron overload.21 
S-ferritin is the most sensitive parameter of a negative iron balance, 
decreasing only in the presence of true iron deficiency, as does 
transferrin saturation. More HIV-uninfected than -infected women 
had decreased s-ferritin levels, and the 95% CI in both younger 
and older women seemed to confirm a trend. Based on s-ferritin, 
most women in both age groups did not have an iron deficiency, 
and no significant difference existed between HIV-infected and 
-uninfected women.
In contrast, an increased s-ferritin is not prognostic of a positive iron 
balance. S-ferritin levels may also increase in chronic diseases unrelated 
to iron metabolism, such as inflammatory diseases.12 It is possible that 
this acute phase protein was reactively elevated, explaining the higher 
median s-ferritin levels in HIV-infected subjects, and was therefore not 
a true reflection of increased iron stores compared to HIV-uninfected 
subjects.
Studies relating s-ferritin levels to bone marrow iron content in various 
chronic disorders suggest that s-ferritin in sick patients without liver 
disease may be interpreted as follows:22
< 30 μg/L: Iron stores depleted
Between 30 and 50 μg/L: Iron stores probably depleted
Between 50 and 150 μg/L: Iron stores uncertain
> 150 μg/L: Iron stores present
These parameter ranges could suggest that HIV-infected and -uninfected 
individuals are not comparable with regard to their laboratory results to 
interpret iron store depletion, with consequences for further therapeutic 
actions in these two groups.
Serum iron levels decrease once body iron stores (as indicated by 
s-ferritin) are depleted, and increase with iron overload. However, on 
its own, serum iron is not a valuable parameter of iron status as it is 
affected by many pathological factors other than the amount of iron 
in the body, such as chronic infections.21 More than 30% of both HIV-
uninfected and -infected women in this study had serum iron levels 
below 0.7 mg/L. In the older group, the percentage of women with 
low serum iron levels was significantly higher in the HIV-uninfected 
than in the HIV-infected women, which is contrary to what is expected 
in chronic infections. In the younger group, the expected trend was 
seen with more HIV-infected women with low serum iron values than 
HIV-uninfected women. However, this was not a significant difference. 
A possible explanation is that older HIV-infected women might have other 
nutritional deficiencies (e.g. pyridoxine deficiency), causing an inability to 
utilise the available iron. Another possibility is the fact that erythropoiesis 
fails to increase in chronic disease anaemia because iron release from 
mononuclear phagocytes, which is the primary source of iron for making 
new red blood cells does not increase.22 HIV status could therefore have 
a similar effect on other related parameters (e.g. Hb and Hct) in both age 
groups (through a number of mechanisms), independent of the effect 
on serum iron per se. This is indeed seen in both age groups, where 
significantly more HIV-infected women had low Hct values compared 
to HIV-uninfected women. Furthermore, more HIV-infected women in 
this study had low Hb levels when compared to HIV-uninfected women, 
and the difference was close to significant. Hb alone is unsuitable as a 
diagnostic tool in cases of suspected iron deficiency anaemia because it 
is affected only late in the disease, it cannot distinguish iron deficiency 
from other types of anaemia, and Hb values in normal individuals vary 
widely.12
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Serum transferrin is less labile than serum iron, and has a reciprocal 
relationship to iron stores – it increases in uncomplicated iron deficiency 
and decreases in iron overload. Transferrin increases as an adaptive 
mechanism to enhance iron absorption. It can however decrease in 
chronic illnesses associated with low serum iron concentrations, but 
remains unchanged in acute illness.21 A large percentage of women had 
elevated transferrin levels. Significantly fewer older HIV-infected women 
had the expected high serum transferrin levels when compared to HIV-
uninfected women, possibly due to the mechanisms described for low 
serum iron values.
Transferrin saturation decreases only in the presence of true iron 
deficiency.12 In the older group there was no significant difference 
between HIV-infected and -uninfected women in terms of transferrin 
saturation to correlate with the difference between their serum iron 
levels. This might well indicate a masked effect on the serum iron levels 
in the HIV-infected women, as already discussed.
An MCV value below 81 fL indicates that the erythrocytes are microcytic 
(small), while a low MCH indicates that the erythrocytes are hypochromic 
(pale). A microcytic, hypochromic anaemia occurs when body stores are 
depleted and the iron deficiency is severe, but both the MCV and MCH 
remain normal in early iron deficiency. In contrast to iron deficiency 
anaemia, the anaemia of chronic disease is usually, but not always, 
characterised by a normocytic, normochromic blood picture, which 
could explain the relatively low percentage of especially HIV-infected 
women with decreased MCV and MCH. Furthermore, serum iron levels 
and transferrin saturation are low in chronic disease, while iron stores 
are normal,23 as was found in a large percentage of patients included in 
this study.
Increased levels of iron intake have been associated with a significant 
decreased progression rate to AIDS.24,25 Although iron supplementation 
may prevent or treat iron deficiency,11,13 it may also activate HIV expression 
and possibly worsen immunosuppression,9 thereby increasing the rate of 
progression of HIV infection.13 It should therefore be administered with 
caution in HIV-infected patients. 11 Iron supplementation of 60 mg twice 
weekly over four months had no effect on the viral load of anaemic, 
pregnant, HIV-infected women.13 In developing countries, where a high 
prevalence of both HIV infection and iron deficiency exists, Clark and 
Semba10 recommend that the current practice of iron supplementation 
be continued. In the event of anaemia of chronic disease, iron 
supplementation is, however, often not effective, and treatment of 
the underlying pathology will usually result in improvement in the 
anaemia.23
The results of the study indicate that prevalence of HIV infection in 
Mangaung is high, especially among women between 25 and 34 years 
of age. Although, on average, the parameters of iron status did not 
indicate iron deficiency in the different age and HIV-status groups, a 
large percentage of women did have anaemia of chronic disease, with 
HIV-infected women afflicted more often.
Knowledge of the HIV status of a patient is of paramount importance 
in evaluating laboratory results in order to determine future treatment 
or nutritional recommendations and interventions. HIV-infected and 
-uninfected individuals might not be comparable regarding their 
laboratory results to interpret iron store depletion, with consequences 
for further therapeutic actions in these two groups. The progression rate 
to AIDS might also be enhanced by certain interventions.
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